<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar422.anc" start="9619" end="9630" sStart="-1" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="The equivalent of 1.5 ?g total lysate protein was loaded onto each lane of 10% SDS-PAGE gels, separated by electrophoresis, and &lt;b&gt;transferred&lt;/b&gt; to nitrocellulose membranes using a Semi-Dry Trans-Blot apparatus (Bio-Rad)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar422.anc" start="9619" end="9630" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="The equivalent of 1.5 ?g total lysate protein was loaded onto each lane of 10% SDS-PAGE gels, separated by electrophoresis, and &lt;b&gt;transferred&lt;/b&gt; to nitrocellulose membranes using a Semi-Dry Trans-Blot apparatus (Bio-Rad)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/ar422.anc" start="9619" end="9630" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="The equivalent of 1.5 ?g total lysate protein was loaded onto each lane of 10% SDS-PAGE gels, separated by electrophoresis, and &lt;b&gt;transferred&lt;/b&gt; to nitrocellulose membranes using a Semi-Dry Trans-Blot apparatus (Bio-Rad)." />
    <s path="[OANC]/data/written_2/technical/biomed/ar422.anc" start="29361" end="29371" sStart="null" offset="87" sid="r8.suggest.v.0050" wn="3" wnkey="suggest%2:32:02::" text="The processing of golgin-160 and giantin occurred as early as that for PARP, suggesting that these proteins are cleaved during the onset of apoptosis (data not shown)." />
    <s path="[OANC]/data/written_2/technical/biomed/ar422.anc" start="29361" end="29371" sStart="null" offset="87" sid="r8.suggest.v.0050" wn="3" wnkey="suggest%2:32:02::" text="The processing of golgin-160 and giantin occurred as early as that for PARP, suggesting that these proteins are cleaved during the onset of apoptosis (data not shown)." />
    <s path="[OANC]/data/written_2/technical/biomed/ar422.anc" start="29361" end="29371" sStart="null" offset="87" sid="r8.suggest.v.0050" wn="3" wnkey="suggest%2:32:02::" text="The processing of golgin-160 and giantin occurred as early as that for PARP, suggesting that these proteins are cleaved during the onset of apoptosis (data not shown)." />
    <s path="[OANC]/data/written_2/technical/biomed/ar422.anc" start="29361" end="29371" sStart="null" offset="87" sid="r8.suggest.v.0050" wn="3" wnkey="suggest%2:32:02::" text="The processing of golgin-160 and giantin occurred as early as that for PARP, suggesting that these proteins are cleaved during the onset of apoptosis (data not shown)." />
    <s path="[OANC]/data/written_2/technical/biomed/ar422.anc" start="26158" end="26164" sStart="null" offset="558" sid="r8.state.n.0633" wn="2" wnkey="state%1:03:00::" text="It has been speculated that these modified forms of autoantigens may have enhanced immunogenicity through exposure of immunocryptic epitopes that are not generated during antigen processing [ 21 23 37 43 ] . These epitopes could trigger autoimmune responses if presented to the immune system under proinflammatory conditions [ 44 ] , and they may be recognized as surface structures on cytoplasmic organelles that are released to the immune system in aberrant disease states." />
  </sentences>
</list>